Suppr超能文献

免疫抑制 Sprague-Dawley 大鼠内皮化模块驱动的嵌合血管组织工程。

Chimeric vessel tissue engineering driven by endothelialized modules in immunosuppressed Sprague-Dawley rats.

机构信息

Department of Chemical Engineering and Applied Chemistry, Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.

出版信息

Tissue Eng Part A. 2011 Jan;17(1-2):151-60. doi: 10.1089/ten.TEA.2010.0293. Epub 2010 Oct 26.

Abstract

Modular tissue engineering is a means of building functional, vascularized tissues using small (∼1 mm long×0.5 mm diameter) components. While this approach is being explored for its utility in adipose and cardiac tissue engineering and in islet transplantation, the initial question in this study was to assess the fate of the endothelial cells (EC) after transplantation delivered on the surface of modules, without an embedded cell. Rat aortic EC-covered collagen gel modules were transplanted into the omental pouch of allogeneic (outbred) Sprague-Dawley rats with and without immunosuppressive drug treatment (atorvastatin and tacrolimus) for 3-60 days. There was a significant increase in vessel density at all time points in the drug treated rats as compared to untreated rats. Green fluorescent protein (GFP)-positive donor rat aortic EC migrated from the surface of the modules and formed primitive vessels by day 7. In the untreated rats, the GFP-positive cells were not seen after day 7. In drug-treated rats, GFP-positive vessels matured over time, accumulated erythrocytes, were supported by host smooth muscle cells, and formed chimeric vessels that survived until day 60. This resulted in the formation of a densely vascularized, perfusable network by day 60. To our knowledge, this is the first study that demonstrates that primary unmodified EC, without the addition of supporting cells, form a chimeric and stable vascular bed in allogeneic, although drug-treated, animals.

摘要

模块化组织工程是一种使用小(∼1 毫米长×0.5 毫米直径)组件构建功能血管化组织的方法。虽然这种方法正在被探索用于脂肪组织和心脏组织工程以及胰岛移植,但本研究的最初问题是评估在没有嵌入式细胞的情况下,将内皮细胞(EC)移植到模块表面后的命运。将覆盖有大鼠主动脉 EC 的胶原凝胶模块移植到同种异体(远交)Sprague-Dawley 大鼠的大网膜囊中,并用免疫抑制药物(阿托伐他汀和他克莫司)处理 3-60 天。与未处理的大鼠相比,在药物处理的大鼠中,所有时间点的血管密度都显著增加。在第 7 天,GFP 阳性供体大鼠主动脉 EC 从模块表面迁移,并形成原始血管。在未处理的大鼠中,在第 7 天之后没有观察到 GFP 阳性细胞。在药物处理的大鼠中,GFP 阳性血管随着时间的推移成熟,积累红细胞,由宿主平滑肌细胞支持,并形成嵌合血管,可存活至第 60 天。这导致在第 60 天形成了一个密集的血管化、可灌注的网络。据我们所知,这是第一项表明未经修饰的原代 EC,无需添加支持细胞,即可在同种异体(尽管经药物处理)动物中形成嵌合和稳定的血管床的研究。

相似文献

1
Chimeric vessel tissue engineering driven by endothelialized modules in immunosuppressed Sprague-Dawley rats.
Tissue Eng Part A. 2011 Jan;17(1-2):151-60. doi: 10.1089/ten.TEA.2010.0293. Epub 2010 Oct 26.
2
Bone marrow-derived mesenchymal stromal cells enhance chimeric vessel development driven by endothelial cell-coated microtissues.
Tissue Eng Part A. 2012 Feb;18(3-4):285-94. doi: 10.1089/ten.TEA.2011.0393. Epub 2011 Oct 21.
3
Application of an endothelialized modular construct for islet transplantation in syngeneic and allogeneic immunosuppressed rat models.
Tissue Eng Part A. 2011 Aug;17(15-16):2005-15. doi: 10.1089/ten.TEA.2010.0542. Epub 2011 May 16.
4
Fate of endothelialized modular constructs implanted in an omental pouch in nude rats.
Tissue Eng Part A. 2009 Oct;15(10):2875-87. doi: 10.1089/ten.TEA.2008.0494.
6
Fate of modular cardiac tissue constructs in a syngeneic rat model.
J Tissue Eng Regen Med. 2015 Nov;9(11):1247-58. doi: 10.1002/term.1724. Epub 2013 Mar 15.

引用本文的文献

1
Temporal Tissue Remodeling in Volumetric Muscle Injury with Endothelial Cell-Laden Patterned Nanofibrillar Constructs.
Bioengineering (Basel). 2024 Dec 14;11(12):1269. doi: 10.3390/bioengineering11121269.
2
Retention of Human iPSC-Derived or Primary Cells Following Xenotransplantation into Rat Immune-Privileged Sites.
Bioengineering (Basel). 2023 Sep 6;10(9):1049. doi: 10.3390/bioengineering10091049.
3
High-Throughput Bioprinting of Geometrically-Controlled Pre-Vascularized Injectable Microgels for Accelerated Tissue Regeneration.
Adv Healthc Mater. 2023 Sep;12(22):e2202840. doi: 10.1002/adhm.202202840. Epub 2023 May 31.
4
Platform technology for scalable assembly of instantaneously functional mosaic tissues.
Sci Adv. 2015 Aug 21;1(7):e1500423. doi: 10.1126/sciadv.1500423. eCollection 2015 Aug.
5
Mesenchymal stromal cells support endothelial cell interactions in an intramuscular islet transplantation model.
Regen Med Res. 2015 Sep 30;3:1. doi: 10.1186/s40340-015-0010-9. eCollection 2015.
6
Using Del-1 to tip the angiogenic balance in endothelial cells in modular constructs.
Tissue Eng Part A. 2014 Apr;20(7-8):1222-34. doi: 10.1089/ten.TEA.2013.0241. Epub 2014 Feb 11.
7
Fate of modular cardiac tissue constructs in a syngeneic rat model.
J Tissue Eng Regen Med. 2015 Nov;9(11):1247-58. doi: 10.1002/term.1724. Epub 2013 Mar 15.
8
Short term interactions with long term consequences: modulation of chimeric vessels by neural progenitors.
PLoS One. 2012;7(12):e53208. doi: 10.1371/journal.pone.0053208. Epub 2012 Dec 27.
9
The expanding world of tissue engineering: the building blocks and new applications of tissue engineered constructs.
IEEE Rev Biomed Eng. 2013;6:47-62. doi: 10.1109/RBME.2012.2233468. Epub 2012 Dec 20.

本文引用的文献

1
Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue.
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16568-73. doi: 10.1073/pnas.0908381106. Epub 2009 Sep 17.
2
Wound repair at a glance.
J Cell Sci. 2009 Sep 15;122(Pt 18):3209-13. doi: 10.1242/jcs.031187.
3
Prevascularization of cardiac patch on the omentum improves its therapeutic outcome.
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14990-5. doi: 10.1073/pnas.0812242106. Epub 2009 Aug 24.
4
Transplantation of a tissue-engineered human vascularized cardiac muscle.
Tissue Eng Part A. 2010 Jan;16(1):115-25. doi: 10.1089/ten.TEA.2009.0130.
5
Fate of endothelialized modular constructs implanted in an omental pouch in nude rats.
Tissue Eng Part A. 2009 Oct;15(10):2875-87. doi: 10.1089/ten.TEA.2008.0494.
6
7
Atorvastatin down-regulates the primate cellular response to porcine aortic endothelial cells in vitro.
Transplantation. 2008 Sep 15;86(5):733-7. doi: 10.1097/TP.0b013e3181821cad.
8
Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.
Nat Clin Pract Cardiovasc Med. 2008 Jun;5(6):338-49. doi: 10.1038/ncpcardio1211. Epub 2008 May 6.
9
Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2.
J Thromb Haemost. 2008 Apr;6(4):692-700. doi: 10.1111/j.1538-7836.2008.02913.x. Epub 2008 Jan 23.
10
The role of endothelial progenitor cells and statins in endothelial function: a review.
Cardiovasc Hematol Agents Med Chem. 2007 Oct;5(4):265-72. doi: 10.2174/187152507782109836.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验